Autopsy report · NCT00699361
Influence of Pantoprazole on Human Myocardial Contractility at Patients With Congestive Heart Failure
Cause of deathFunding or business
“Study withdrawn for financial issues”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 3
- Sponsor
- Johann Wolfgang Goethe University Hospital
- Sponsor type
- University, hospital or other
- Conditions
- Congestive Heart Failure
- Interventions
- Pantoprazole; Pantoprazole
- Participants
- 0
- Sites
- 1
- Countries
- Germany
Trials that died the same way
- The Influence of Probiotics on Body Weight and Composition
“study withdrawn due to funding” - Bexarotene and Fenretinide as Addition to Antipsychotic Treatment in Schizophrenia Patients
“The study withdrawn due to lack financial support” - A Study of the Safety and Efficacy of Pancreatic Endocrine Cell Clusters Implanted Into the Omentum of Type 1 Diabetes Patients With Severe Hypoglycemia
“Study is being withdrawn for business reasons” - ²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor Stem Cell Transplant for the Treatment of Newly Diagnosed, Recurrent, or Refractory High-Risk Multiple Myeloma
“Study withdrawn before opening to accrual.” - Adherence to ASV Therapy in Heart Failure With Preserved Ejection Fraction Feasibility Study
“Funding for study was withdrawn”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.